Price T Rowe Associates Inc Glaukos Corp Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Glaukos Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 35,182 shares of GKOS stock, worth $3.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,182

Previous 30,955 13.66%

Holding current value

$3.64 Million

Previous $4.03 Million 30.82%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$126.42 - $152.67 $534,377 - $645,336	4,227 Added 13.66%	35,182 $5.28 Million
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $190,995 - $227,590	-1,681 Reduced 5.15%	30,955 $4.03 Million
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $203,298 - $268,891	2,272 Added 7.48%	32,636 $3.86 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $21.7 Million - $27.3 Million	-283,560 Reduced 90.33%	30,364 $2.86 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $17.1 Million - $24.5 Million	287,736 Added 1098.73%	313,924 $25 Million
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $3,392 - $3,875	49 Added 0.19%	26,188 $1.97 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $33,125 - $51,912	729 Added 2.87%	26,139 $1.86 Million
Q1 2023 May 15, 2023	SELL	$43.88 - $52.48 $219,531 - $262,557	-5,003 Reduced 16.45%	25,410 $1.27 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $24,696 - $34,938	605 Added 2.03%	30,413 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $183,472 - $229,105	3,917 Added 15.13%	29,808 $1.59 Million
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $39,008 - $71,358	1,119 Added 4.52%	25,891 $1.18 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $81,877 - $106,793	1,847 Added 8.06%	24,772 $1.43 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $27,665 - $39,152	-687 Reduced 2.91%	22,925 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $40,647 - $72,185	-857 Reduced 3.5%	23,612 $1.14 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $76,201 - $101,901	1,043 Added 4.45%	24,469 $2.08 Million
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $12,677 - $17,535	-180 Reduced 0.76%	23,426 $1.97 Million
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $1.15 Million - $1.78 Million	23,606 New	23,606 $1.78 Million

Others Institutions Holding GKOS

# of Institutions

355

Shares Held

50.1M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.92B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Glaukos Corp Transaction History